Furthermore, CTHRC1 may be a useful marker for primary melanoma (Figure 5) and BRMS1 serves an important marker for metastatic melanoma distinguishing from dysplastic nevi (Figure 6). This evidence concerns the gene BRMS1 and dysplastic nevus.